Insights on specification setting challenges and opportunities
Patient-Centric Commercial Specifications for Biotherapeutic Products, Strategies and Case studies
Basic regulatory science behind drug substance & drug product specifications of monoclonal antibodies
Advertisement Contributed by Lukas MoglerPrincipal Scientist, Forensic Chemistry, Drug Product Services, LonzaConnectAdvertisementAdvertisement[lwp_divi_breadcrumbs _builder_version="4.27.4" _module_preset="default" hover_enabled="0"...
Analytical Quality by Design: from Quality Target Product Profile to the Analytical Target Profile
Advertisement Contributed by Lukas MoglerPrincipal Scientist, Forensic Chemistry, Drug Product Services, LonzaConnectAdvertisementAdvertisement[lwp_divi_breadcrumbs _builder_version="4.27.4" _module_preset="default" hover_enabled="0"...
Critical Analytical Procedure Parameters and Risk Assessments
Advertisement Contributed by Lukas MoglerPrincipal Scientist, Forensic Chemistry, Drug Product Services, LonzaConnectAdvertisementAdvertisement[lwp_divi_breadcrumbs _builder_version="4.27.4" _module_preset="default" hover_enabled="0"...
Analytical Procedure Control Strategy (ACPS)
Advertisement Contributed by Lukas MoglerPrincipal Scientist, Forensic Chemistry, Drug Product Services, LonzaConnectAdvertisementAdvertisement[lwp_divi_breadcrumbs _builder_version="4.27.4" _module_preset="default" hover_enabled="0"...
ICH Q14 Analytical Procedure Development
Advertisement Contributed by Lukas MoglerPrincipal Scientist, Forensic Chemistry, Drug Product Services, LonzaConnectAdvertisementAdvertisement
Advertisement
Advertisement
Advertisement